Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bateman

Showing results (281-290 of 533) with videos related to

Pageof 54
Sort By:
Brain Communications|April 12, 2021
Detection of β-amyloid positivity in Alzheimer's Disease Neuroimaging Initiative participants with demographics, cognition, MRI and plasma biomarkersDuygu Tosun, Dallas Veitch, Paul Aisen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 16, 2025
The CentiMarker project: Standardizing quantitative Alzheimer's disease fluid biomarkers for biologic interpretationGuoqiao Wang, Yan Li, Chengjie Xiong, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersAleksandra Beric, Wenjing Lin, Gina Jerome, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersCarling G Robinson, Alexa Pichet Binette, Kanta Horie, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2009
Synthesis and evaluation of N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-aminopropanamide as human cannabinoid-1 receptor (CB1R) inverse agonistsWu Du, James P Jewell, Linus S Lin, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 4, 2013
Lymphatic absorption, metabolism, and excretion of a therapeutic peptide in dogs and ratsYan Zou, Thomas J Bateman, Christine Adreani, et al.
Nature Communications|May 22, 2019
Aβ34 is a BACE1-derived degradation intermediate associated with amyloid clearance and Alzheimer's disease progressionFilip Liebsch, Luka Kulic, Charlotte Teunissen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisMaulikkumar P Patel, Arda Cetin, Matthew Johnson, et al.
Medrxiv : the Preprint Server for Health Sciences|August 7, 2024
The CentiMarker Project: Standardizing Quantitative Alzheimer's disease Fluid Biomarkers for Biologic InterpretationGuoqiao Wang, Yan Li, Chengjie Xiong, et al.
Journal of the International Neuropsychological Society : JINS|September 5, 2022
Unsupervised high-frequency smartphone-based cognitive assessments are reliable, valid, and feasible in older adults at risk for Alzheimer's diseaseJessica Nicosia, Andrew J Aschenbrenner, David A Balota, et al.
Pageof 54

Showing results (281-290 of 533) with videos related to

Sort By:
Pageof 54
Brain Communications|April 12, 2021
Detection of β-amyloid positivity in Alzheimer's Disease Neuroimaging Initiative participants with demographics, cognition, MRI and plasma biomarkersDuygu Tosun, Dallas Veitch, Paul Aisen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 16, 2025
The CentiMarker project: Standardizing quantitative Alzheimer's disease fluid biomarkers for biologic interpretationGuoqiao Wang, Yan Li, Chengjie Xiong, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersAleksandra Beric, Wenjing Lin, Gina Jerome, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersCarling G Robinson, Alexa Pichet Binette, Kanta Horie, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2009
Synthesis and evaluation of N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-aminopropanamide as human cannabinoid-1 receptor (CB1R) inverse agonistsWu Du, James P Jewell, Linus S Lin, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 4, 2013
Lymphatic absorption, metabolism, and excretion of a therapeutic peptide in dogs and ratsYan Zou, Thomas J Bateman, Christine Adreani, et al.
Nature Communications|May 22, 2019
Aβ34 is a BACE1-derived degradation intermediate associated with amyloid clearance and Alzheimer's disease progressionFilip Liebsch, Luka Kulic, Charlotte Teunissen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisMaulikkumar P Patel, Arda Cetin, Matthew Johnson, et al.
Medrxiv : the Preprint Server for Health Sciences|August 7, 2024
The CentiMarker Project: Standardizing Quantitative Alzheimer's disease Fluid Biomarkers for Biologic InterpretationGuoqiao Wang, Yan Li, Chengjie Xiong, et al.
Journal of the International Neuropsychological Society : JINS|September 5, 2022
Unsupervised high-frequency smartphone-based cognitive assessments are reliable, valid, and feasible in older adults at risk for Alzheimer's diseaseJessica Nicosia, Andrew J Aschenbrenner, David A Balota, et al.
Pageof 54